Drug Safety Alert: IPC Flags Adverse Reactions to Metronidazole, Luliconazole, Dalteparin, Gliclazide, and Tramadol Susmita Roy28 March 2025 6:00 PM ISTNew Delhi: The Indian Pharmacopoeia Commission (IPC), through its recently issued drug safety alert for the month of March, has revealed adverse drug...
NPPA Allows 1.74% Price Hike for Essential Drugs, No Govt Approval Needed Farhat Nasim27 March 2025 7:48 PM ISTNew Delhi: The National Pharmaceutical Pricing Authority (NPPA) has permitted manufacturers to increase the Maximum Retail Price (MRP) of scheduled...
307 Cases of Drug Price Violations Surface, Big Pharma To Face Heat? Farhat Nasim26 March 2025 8:34 PM ISTNew Delhi: The issue of drug pricing violations has come under scrutiny, with the Parliamentary Standing Committee on Chemicals and Fertilizers...
Setback to Roche: Plea Against Natco on Risdiplam Patent Rejected by Delhi HC Farhat Nasim25 March 2025 5:31 PM ISTNew Delhi: In a major relief to Indian drugmaker Natco Pharma, the Delhi High Court has rejected an interim injunction plea filed by Swiss...
With Rs 3,788 Crore in Savings, Govt Eyes Adding More Drugs Under NLEM Farhat Nasim24 March 2025 5:40 PM IST"The arbitrary exclusion of essential medicines from price control must be addressed immediately," the Govt Panel said.
Protocol doesn't address all aims of phase IV CT: CDSCO Panel Tells Sun Pharma Lab on Esomeprazole Dual Release Gastro Resistant Tablets Dr. Divya Colin23 March 2025 6:00 PM ISTNew Delhi: Citing that the proposed study protocol of Esomeprazole Dual Release GastroResistant Tablets 80mg does not address all the aims of the...
Govt Reconstitutes DTAB, AIOCD Protests Exclusion from Drug Regulatory Body Farhat Nasim22 March 2025 2:41 PM ISTNew Delhi: The Central Government, through a notification issued by the Ministry of Health and Family Welfare has officially reconstituted the...
Dr Reddy's Laboratories Gets CDSCO Panel Nod To Import, Market Saccharomyces Boulardii CNCM-I 745 Powder in Sachet Dr. Divya Colin21 March 2025 6:00 PM ISTNew Delhi: Granting the bioequivalence study waiver and clinical trial study waiver, the Subject Expert Committee (SEC) functional under the Central...
Himalaya's Liv.52 Trademark Protected: Delhi HC Fines Liv-333 Maker Rs 30 Lakh for Infringement Farhat Nasim20 March 2025 3:39 PM ISTNew Delhi: The Delhi High Court granted a permanent injunction in favor of Himalaya Global Holdings Ltd. against Rajasthan Aushdhalaya Private Limited...
CDSCO Bans Chloramphenicol, Nitrofurans in food producing animal rearing system Dr. Divya Colin19 March 2025 6:00 PM ISTNew Delhi: The Central Drug Standard Control Organisation (CDSCO), Ministry of Fertiliser and Chemicals, Government of India, has banned the import,...
Cadila Pharma Employee Found Dead Inside Toilet, Investigation Underway Farhat Nasim18 March 2025 7:24 PM ISTAhmedabad: In a tragic and mysterious incident at Cadila Pharmaceuticals' facility in Dholka, a 35-year-old employee, Varsha Rajput, was found dead in...
Generate PMS data to assess patient safety : CDSCO Panel Tells Novartis Healthcare on additional indications of Secukinumab Dr. Divya Colin17 March 2025 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has opined the drug major...
